{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T02:42:47Z","timestamp":1779244967653,"version":"3.51.4"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.cyto.2020.155059","type":"journal-article","created":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T06:24:55Z","timestamp":1584599095000},"page":"155059","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["STAT3-driven hematopoiesis and lymphopoiesis abnormalities are dependent on serine phosphorylation"],"prefix":"10.1016","volume":"130","author":[{"given":"Jesse J.","family":"Balic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine L.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruby","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Gough","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew P.","family":"McCormack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brendan J.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2020.155059_b0005","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nm1249","article-title":"Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target","volume":"11","author":"Chiarle","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.cyto.2020.155059_b0010","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1182\/blood.V95.12.3765.012k50_3765_3770","article-title":"Constitutive Stat3, Tyr705, and Ser727 phosphorylation in acute myeloid leukemia cells caused by the autocrine secretion of interleukin-6","volume":"95","author":"Schuringa","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2020.155059_b0015","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1182\/blood.V99.1.252","article-title":"Constitutive activity of signal transducer and activator of transcription 3 protein in acute myeloid leukemia blasts is associated with short disease-free survival","volume":"99","author":"Benekli","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2020.155059_b0020","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1158\/1078-0432.CCR-14-0683","article-title":"Clinical implications of phosphorylated STAT3 expression in de novo diffuse large B-cell lymphoma","volume":"20","author":"Ok","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cyto.2020.155059_b0025","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis","volume":"7","author":"Levine","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cyto.2020.155059_b0030","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2020.155059_b0035","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.2741\/3597","article-title":"Regulation of hematopoietic cell development and function by Stat3","volume":"14","author":"Hankey","year":"2009","journal-title":"Front. Biosci. (Landmark Ed)"},{"key":"10.1016\/j.cyto.2020.155059_b0040","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41577-018-0066-7","article-title":"Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer","volume":"18","author":"Jones","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cyto.2020.155059_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08977194.2018.1473393","article-title":"STAT3: a multifaceted oncoprotein","volume":"36","author":"Guanizo","year":"2018","journal-title":"Growth Factors"},{"key":"10.1016\/j.cyto.2020.155059_b0050","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1182\/blood-2013-02-484196","article-title":"STAT3 supports experimental K-RasG12D\u2013induced murine myeloproliferative neoplasms dependent on serine phosphorylation","volume":"124","author":"Gough","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2020.155059_b0055","doi-asserted-by":"crossref","first-page":"5272","DOI":"10.1158\/0008-5472.CAN-19-0974","article-title":"Serine-phosphorylated STAT3 promotes tumorigenesis via modulation of RNA polymerase transcriptional activity","volume":"79","author":"Balic","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.cyto.2020.155059_b0060","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1182\/blood-2004-09-3751","article-title":"The threshold of gp130-dependent STAT3 signaling is critical for normal regulation of hematopoiesis","volume":"105","author":"Jenkins","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2020.155059_b0065","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1182\/blood-2006-08-040352","article-title":"Pathologic consequences of STAT3 hyperactivation by IL-6 and IL-11 during hematopoiesis and lymphopoiesis","volume":"109","author":"Jenkins","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2020.155059_b0070","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1080\/10428194.2017.1397668","article-title":"STAT3 inhibition as a therapeutic strategy for leukemia","volume":"59","author":"Kanna","year":"2018","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.cyto.2020.155059_b0075","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1126\/science.1171721","article-title":"Mitochondrial STAT3 supports Ras-dependent oncogenic transformation","volume":"324","author":"Gough","year":"2009","journal-title":"Science"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466620300752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466620300752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:54:39Z","timestamp":1760907279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466620300752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":15,"alternative-id":["S1043466620300752"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2020.155059","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"STAT3-driven hematopoiesis and lymphopoiesis abnormalities are dependent on serine phosphorylation","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2020.155059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155059"}}